What does PHARMACIE FOCH do?

PHARMACIE FOCH is a pharmacy in Châtelet. Private Limited, started on 8 September 2006, 2 establishments.

What is the address of PHARMACIE FOCH?

The registered office of PHARMACIE FOCH is located at Rue Maréchal Foch 43, 6200 Châtelet.

Is PHARMACIE FOCH still active?

Yes. According to the CBE (2 November 2026) PHARMACIE FOCH is active, legal situation “Normale toestand”, started on 8 September 2006.

Is PHARMACIE FOCH registered on Peppol?

Yes, PHARMACIE FOCH is registered on the Peppol network with ID 0208:0883397905.

What is the enterprise number of PHARMACIE FOCH?

The enterprise number of PHARMACIE FOCH is BE0883397905.

When was PHARMACIE FOCH founded?

PHARMACIE FOCH was founded on 8 September 2006.

Who are the directors of PHARMACIE FOCH?

According to the 2025 annual accounts, the directors of PHARMACIE FOCH are: BRUNO ROUCOUR, BENEDICTE JAUMAIN.

Is PHARMACIE FOCH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 2006; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did PHARMACIE FOCH make in 2025?

PHARMACIE FOCH posted a profit after taxes of € 422,781 in financial year 2025.

What is the revenue of PHARMACIE FOCH?

As a small company, PHARMACIE FOCH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 621,224.

How much does an employee at PHARMACIE FOCH earn?

The average wage cost per full-time employee at PHARMACIE FOCH was € 73,900 in 2024: staff costs of € 258,640 for 3.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE FOCH have?

According to the 2025 annual accounts, PHARMACIE FOCH has 0 full-time equivalents (FTE).

PHARMACIE FOCH (Private Limited) - Châtelet

Dossier PHARMACIE FOCH, printed on 2 November 2026 from databakkes.be/en/0883397905/pharmacie-foch. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE FOCH from Châtelet, company number BE0883397905, closed financial year 2025 with a result of € 422,781 after tax. For that financial year PHARMACIE FOCH recorded a gross margin of € 621,224 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 89,022 to € 422,781. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 1.8 million

▲ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 422,781

▲ € 333,759 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 86,038

▼ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.8 million.

People and assets in 2025

Full-time equivalents

▼ 3.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 2,880

▼ 63% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 602,981

▼ 21% vs 2024

€ 99,301 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 4,294

▼ 98% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,456

▼ 84% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 502,090 Gross margin 2022: € 502,090 First fiscal year in the series	€ 405,871 Gross margin 2023: € 405,871 ▼ 19% vs 2022 (€ 502,090) Unfavourable step	€ 463,507 Gross margin 2024: € 463,507 ▲ 14% vs 2023 (€ 405,871) Favourable step	€ 621,224 Gross margin 2025: € 621,224 ▲ 34% vs 2024 (€ 463,507) Favourable step	▲ 34%
Profit after taxes	€ 122,511 Profit after taxes 2022: € 122,511 First fiscal year in the series	€ 69,879 Profit after taxes 2023: € 69,879 ▼ 43% vs 2022 (€ 122,511) Unfavourable step	€ 89,022 Profit after taxes 2024: € 89,022 ▲ 27% vs 2023 (€ 69,879) Favourable step	€ 422,781 Profit after taxes 2025: € 422,781 ▲ € 333,759 vs 2024 (€ 89,022) Favourable step	▲ € 333,759
Equity	€ 1,203,785 Equity 2022: € 1,203,785 First fiscal year in the series	€ 1,273,664 Equity 2023: € 1,273,664 ▲ 6% vs 2022 (€ 1,203,785) Favourable step	€ 1,362,686 Equity 2024: € 1,362,686 ▲ 7% vs 2023 (€ 1,273,664) Favourable step	€ 1,785,467 Equity 2025: € 1,785,467 ▲ 31% vs 2024 (€ 1,362,686) Favourable step	▲ 31%
Total debts	€ 1,688,710 Total debts 2022: € 1,688,710 First fiscal year in the series	€ 1,893,865 Total debts 2023: € 1,893,865 ▲ 12% vs 2022 (€ 1,688,710) Unfavourable step	€ 1,683,876 Total debts 2024: € 1,683,876 ▼ 11% vs 2023 (€ 1,893,865) Favourable step	€ 1,746,728 Total debts 2025: € 1,746,728 ▲ 4% vs 2024 (€ 1,683,876) Unfavourable step	▲ 4%
Cash	€ 133,450 Cash 2022: € 133,450 First fiscal year in the series	€ 140,578 Cash 2023: € 140,578 ▲ 5% vs 2022 (€ 133,450) Favourable step	€ 165,028 Cash 2024: € 165,028 ▲ 17% vs 2023 (€ 140,578) Favourable step	€ 86,038 Cash 2025: € 86,038 ▼ 48% vs 2024 (€ 165,028) Unfavourable step	▼ 48%
Land & buildings	€ 761,957 Land & buildings 2022: € 761,957 First fiscal year in the series	€ 735,844 Land & buildings 2023: € 735,844 ▼ 3% vs 2022 (€ 761,957) Unchanged	€ 715,342 Land & buildings 2024: € 715,342 ▼ 3% vs 2023 (€ 735,844) Unchanged	€ 689,677 Land & buildings 2025: € 689,677 ▼ 4% vs 2024 (€ 715,342) Unchanged	▼ 4%
Retained profit	€ 1,191,385 Retained profit 2022: € 1,191,385 First fiscal year in the series	€ 1,261,264 Retained profit 2023: € 1,261,264 ▲ 6% vs 2022 (€ 1,191,385) Favourable step	€ 1,350,286 Retained profit 2024: € 1,350,286 ▲ 7% vs 2023 (€ 1,261,264) Favourable step	€ 1,773,067 Retained profit 2025: € 1,773,067 ▲ 31% vs 2024 (€ 1,350,286) Favourable step	▲ 31%
Bank debt	€ 1,110,301 Bank debt 2022: € 1,110,301 First fiscal year in the series	€ 935,795 Bank debt 2023: € 935,795 ▼ 16% vs 2022 (€ 1,110,301) Favourable step	€ 764,954 Bank debt 2024: € 764,954 ▼ 18% vs 2023 (€ 935,795) Favourable step	€ 602,981 Bank debt 2025: € 602,981 ▼ 21% vs 2024 (€ 764,954) Favourable step	▼ 21%
Balance sheet total	€ 2,892,495 Balance sheet total 2022: € 2,892,495 First fiscal year in the series	€ 3,167,529 Balance sheet total 2023: € 3,167,529 ▲ 10% vs 2022 (€ 2,892,495) Unchanged	€ 3,046,562 Balance sheet total 2024: € 3,046,562 ▼ 4% vs 2023 (€ 3,167,529) Unchanged	€ 3,632,196 Balance sheet total 2025: € 3,632,196 ▲ 19% vs 2024 (€ 3,046,562) Unchanged	▲ 19%
Employees (FTE)	4.4 Employees (FTE) 2022: 4.4 First fiscal year in the series	3.4 Employees (FTE) 2023: 3.4 ▼ 1 vs 2022 (4.4) Unchanged	3.5 Employees (FTE) 2024: 3.5 ▲ 0.1 vs 2023 (3.4) Unchanged	0 Employees (FTE) 2025: 0 ▼ 3.5 vs 2024 (3.5) Unchanged	▼ 3.5

Key figures of PHARMACIE FOCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE FOCH?

What happened at PHARMACIE FOCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 422,781 (▲ € 333,759 vs 2024). filed late Source: NBB ↗
Dec 13, 2012 New establishment in Châtelet. KBO
Dec 13, 2012 New establishment in Châtelet. KBO
Sep 8, 2006 Start of the company according to the CBE. KBO

In short

From € 122,511 profit in 2022 to € 422,781 profit in 2025.

Paid € 88,826 in corporate taxes since 2022.

Best year ever: 2025, with € 422,781 profit.

On average € 132,400 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

BRUNO ROUCOUR 100%

PHARMACIE FOCH

Pharmacie Antoine 100%

Pharmacie Haegeman 50%

Behind PHARMACIE FOCH are BRUNO ROUCOUR and BENEDICTE JAUMAIN. The shares are held by BRUNO ROUCOUR (100%). It owns 100% of Pharmacie Antoine and 50% of Pharmacie Haegeman itself.

Directors

According to the 2025 annual accounts

BRUNO ROUCOUR

Director

BENEDICTE JAUMAIN

Director

Shareholders

BRUNO ROUCOUR

100%

Participations

Pharmacie Antoine

100%

Pharmacie Haegeman

50%

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Maréchal Foch 43

6200 Châtelet

2.214.724.883

Rue des Haies 142

6200 Châtelet

Active since 13 December 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0883.397.905

VAT number

BE 0883.397.905

Registered office

Rue Maréchal Foch 43, 6200 Châtelet

Names & denominations

PHARMACIE FOCH

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 September 2006

Peppol

Active · Active since 8 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE FOCH

Financials

What happened to PHARMACIE FOCH?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions